Based on the observation that claudin 1 is down regulated or absent in invasive HBC [19-22], and that an absence of claudin 1 was shown to correlate with poor prognosis and shorter patient survival time [23], it has been speculated that claudin 1 could be a putative tumor suppressor in breast cancer. Here, CLDN1 is linked to neoplasm.